{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:23:16Z","timestamp":1787242996335,"version":"build-2736575974"},"reference-count":333,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118601","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:00:45Z","timestamp":1758582045000},"page":"118601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Fighting cancer smarter: Using hydrogel delivery systems to target chemokines"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0653-2724","authenticated-orcid":false,"given":"Hossein","family":"Khorramdelazad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Yaraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shirzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Boroumand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Arfaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Kheyri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Daj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Keykhaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.biopha.2025.118601_bib1","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"Febs J."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081692","article-title":"Regulation of chemokine function: the roles of GAG-Binding and Post-Translational nitration","volume":"18","author":"Thompson","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118601_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"24","key":"10.1016\/j.biopha.2025.118601_bib5","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1158\/0008-5472.CAN-12-2027","article-title":"Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response","volume":"72","author":"Franciszkiewicz","year":"2012","journal-title":"Cancer Res"},{"issue":"23","key":"10.1016\/j.biopha.2025.118601_bib6","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.3390\/cancers13236132","article-title":"Multifaceted roles of chemokines and chemokine receptors in tumor immunity","volume":"13","author":"Matsuo","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib8","doi-asserted-by":"crossref","DOI":"10.4161\/onci.25474","article-title":"A role for CCL2 in both tumor progression and immunosurveillance","volume":"2","author":"Li","year":"2013","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020287","article-title":"Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers","volume":"12","author":"Do","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118601_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front Immunol."},{"issue":"6-7","key":"10.1016\/j.biopha.2025.118601_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.imbio.2017.12.001","article-title":"Applications of chemokines as adjuvants for vaccine immunotherapy","volume":"223","author":"Mohan","year":"2018","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/14760584.6.2.267","article-title":"Clinical utilization of chemokines to combat cancer: the double-edged sword","volume":"6","author":"Dell'Agnola","year":"2007","journal-title":"Expert Rev. Vaccin."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S1679-45082015RB3438","article-title":"Chemokines and immunity","volume":"13","author":"Palomino","year":"2015","journal-title":"Einst (Sao Paulo)"},{"issue":"9","key":"10.1016\/j.biopha.2025.118601_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092142","article-title":"Recombinant viral vectors for therapeutic programming of tumour microenvironment: advantages and limitations","volume":"10","author":"Spunde","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118601_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115083","article-title":"Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer","volume":"202","author":"Mikhail","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"28","key":"10.1016\/j.biopha.2025.118601_bib19","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.biomaterials.2009.06.001","article-title":"In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells","volume":"30","author":"Singh","year":"2009","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/gels10070437","article-title":"Biomimetic hydrogel strategies for cancer therapy","volume":"10","author":"Alshehri","year":"2024","journal-title":"Gels"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-024-01852-x","article-title":"Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.118601_bib22","doi-asserted-by":"crossref","first-page":"1121887","DOI":"10.3389\/fbioe.2023.1121887","article-title":"Application of injectable hydrogels in cancer immunotherapy","volume":"11","author":"Liu","year":"2023","journal-title":"Front Bioeng. Biotechnol."},{"issue":"386","key":"10.1016\/j.biopha.2025.118601_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai9044","article-title":"Glycosaminoglycan-based hydrogels capture inflammatory chemokines and rescue defective wound healing in mice","volume":"9","author":"Lohmann","year":"2017","journal-title":"Sci. Transl. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.trecan.2019.05.001","article-title":"Targeting the tumor microenvironment of leukemia and lymphoma","volume":"5","author":"H\u00f6pken","year":"2019","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00062752-200107000-00001","article-title":"Hematologic malignancies","volume":"8","author":"Gilliland","year":"2001","journal-title":"Curr. Opin. Hematol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bjh.16456","article-title":"Dissecting the role of the CXCL12\/CXCR4 axis in acute myeloid leukaemia","volume":"189","author":"Ladikou","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2025.118601_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174831","article-title":"The contributory roles of the CXCL12\/CXCR4\/CXCR7 axis in normal and malignant hematopoiesis: a possible therapeutic target in hematologic malignancies","volume":"920","author":"Mehrpouri","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118601_bib29","article-title":"Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia","volume":"9","author":"Wang","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.biopha.2025.118601_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.766275","article-title":"Deciphering tumor niches: lessons from solid and hematological malignancies","volume":"12","author":"Mancini","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib31","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/s41375-024-02326-3","article-title":"CXCR4 as a therapeutic target in acute myeloid leukemia","volume":"38","author":"Korbecki","year":"2024","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib32","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/ajh.25943","article-title":"Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed\/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients","volume":"95","author":"Borthakur","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/cncr.33338","article-title":"BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed\/refractory acute myelogenous leukemia: an open-label safety and efficacy phase 2a study","volume":"127","author":"Borthakur","year":"2021","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib34","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2011.43","article-title":"A novel role for CCL3 (MIP-1\u03b1) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function","volume":"25","author":"Vallet","year":"2011","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.biopha.2025.118601_bib35","first-page":"3744","article-title":"MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts","volume":"110","author":"Vallet","year":"2007","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.biopha.2025.118601_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846310","article-title":"Targeting chemokine receptor CCR1 as a potential therapeutic approach for multiple myeloma","volume":"13","author":"Gilchrist","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"21","key":"10.1016\/j.biopha.2025.118601_bib37","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V124.21.3380.3380","article-title":"Chemokines CCL14 and CCL3 facilitate Monocytes\/Macrophage infiltration in multiple myeloma bone marrow","volume":"124","author":"Li","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib38","first-page":"1020","article-title":"Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs","volume":"118","author":"Rehm","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.biopha.2025.118601_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662866","article-title":"Of lymph nodes and CLL cells: deciphering the role of CCR7 in the pathogenesis of CLL and understanding its potential as therapeutic target","volume":"12","author":"Cuesta-Mateos","year":"2021","journal-title":"Front. Immunol."},{"issue":"702","key":"10.1016\/j.biopha.2025.118601_bib40","doi-asserted-by":"crossref","first-page":"eabo3826","DOI":"10.1126\/scitranslmed.abo3826","article-title":"Targeting CCR7-PI3K\u03b3 overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma","volume":"15","author":"Mastini","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118601_bib41","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-LB015","article-title":"Abstract LB015: CCR7-expressing T-cell acute lymphoblastic leukemia mouse model provides a platform for developing novel anti-CCR7 therapies to prevent CNS invasion","volume":"82","author":"Torres","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118601_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-020-00234-z","article-title":"CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia","volume":"8","author":"Cuesta-Mateos","year":"2020","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-021-00296-9","article-title":"Cutaneous t cell lymphoma","volume":"7","author":"Dummer","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib44","article-title":"CXCL13-CXCR5 axis: regulation in inflammatory diseases and cancer","volume":"1877","author":"Wang","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA)Reviews Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153004","article-title":"CXCL13 is expressed in various haematological disorders other than angioimmunoblastic T-cell lymphoma","volume":"216","author":"De Mestral","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2141.2002.03832.x","article-title":"CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant b cells","volume":"119","author":"Husson","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41467-020-20488-3","article-title":"CXCR5 CAR-T cells simultaneously target b cell non-Hodgkin\u2019s lymphoma and tumor-supportive follicular t helper cells","volume":"12","author":"Bunse","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118601_bib48","first-page":"1","article-title":"CCL2 in the tumor microenvironment","author":"O\u2019Connor","year":"2021","journal-title":"Tumor Microenviron. Role ChemokinesPart B"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib49","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","article-title":"The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"7355","key":"10.1016\/j.biopha.2025.118601_bib50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118601_bib51","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-LB-194","article-title":"Abstract LB-194: targeting tumor associated myeloid cells with CCR2 inhibitor PF-04136309 enhances gemcitabine\/paclitaxel and doxorubicin anti-tumor activity","volume":"77","author":"Farina","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118601_bib52","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10637-019-00830-3","article-title":"Phase 1b study of a small molecule antagonist of human chemokine (CC motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel\/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma","volume":"38","author":"Noel","year":"2020","journal-title":"Investig. N. Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib53","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib54","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12957-021-02291-6","article-title":"The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis","volume":"19","author":"Zhang","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"19","key":"10.1016\/j.biopha.2025.118601_bib55","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1158\/0008-5472.CAN-19-1167","article-title":"Recent advances targeting CCR5 for cancer and its role in immuno-oncology","volume":"79","author":"Jiao","year":"2019","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib56","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1517\/14728222.2014.949238","article-title":"The potential to target CCL5\/CCR5 in breast cancer","volume":"18","author":"Velasco-Vel\u00e1zquez","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2025.118601_bib57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejca.2022.03.017","article-title":"Pembrolizumab and maraviroc in refractory mismatch repair proficient\/microsatellite-stable metastatic colorectal cancer\u2013the PICCASSO phase I trial","volume":"167","author":"Haag","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib58","first-page":"285","article-title":"Safety and efficacy of vicriviroc (MK-7690) in combination with pembrolizumab in patients with advanced or metastatic microsatellite stable colorectal cancer","volume":"23","author":"Bessudo","year":"2024","journal-title":"Clin. Colorectal Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/bjc.2014.572","article-title":"The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer","volume":"112","author":"Ward","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019495","article-title":"Tumor-associated macrophages recruit CCR6+ regulatory t cells and promote the development of colorectal cancer via enhancing CCL20 production in mice","volume":"6","author":"Liu","year":"2011","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib61","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3390\/cancers12071888","article-title":"Relevance of regulatory t cells during colorectal cancer development","volume":"12","author":"Olguin","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118601_bib62","doi-asserted-by":"crossref","first-page":"1574327","DOI":"10.3389\/fimmu.2025.1574327","article-title":"The role of treg cells in colorectal cancer and the immunotherapy targeting treg cells","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/cancers10010006","article-title":"Immune evasion in pancreatic cancer: from mechanisms to therapy","volume":"10","author":"Martinez-Bosch","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118601_bib64","doi-asserted-by":"crossref","first-page":"1582305","DOI":"10.3389\/fimmu.2025.1582305","article-title":"Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets","volume":"16","author":"Pan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118601_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-29-37","article-title":"CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo","volume":"29","author":"He","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118601_bib66","article-title":"Lmu","author":"Knott","year":"2019","journal-title":"Regul. Regul. T Cellattracting chemokine CCL22 Solid Tumors"},{"key":"10.1016\/j.biopha.2025.118601_bib67","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1007\/s13277-015-3133-8","article-title":"Macrophage-derived chemokine CCL22 and regulatory t cells in ovarian cancer patients","volume":"36","author":"Wertel","year":"2015","journal-title":"Tumor Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib68","first-page":"367","article-title":"Genetic polymorphisms of CCL22 and CCR4 in patients with lung cancer","volume":"39","author":"Erfani","year":"2014","journal-title":"Iran. J. Med. Sci."},{"issue":"21","key":"10.1016\/j.biopha.2025.118601_bib69","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.3390\/cancers13215542","article-title":"CCR4 as a therapeutic target for cancer immunotherapy","volume":"13","author":"Yoshie","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib70","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI82976","article-title":"A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer","volume":"127","author":"Berlato","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12967-023-04686-3","article-title":"CD4+ CCR8+ tregs in ovarian cancer: a potential effector tregs for immune regulation","volume":"21","author":"Liu","year":"2023","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib72","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s00262-022-03196-3","article-title":"Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1+ fibroblast and CCR8+ treg cell interactions","volume":"71","author":"Wang","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-025-03286-x","article-title":"CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating tregs into less immunosuppressive phenotype","volume":"44","author":"Tian","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib74","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.mvr.2011.06.011","article-title":"CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation","volume":"82","author":"Singh","year":"2011","journal-title":"Microvasc. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib75","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2015.02.021","article-title":"CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis","volume":"361","author":"Xiao","year":"2015","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib76","doi-asserted-by":"crossref","first-page":"748","DOI":"10.21037\/tcr-20-2539","article-title":"An inter-correlation among chemokine (CXC motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients","volume":"10","author":"Gu","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118601_bib77","doi-asserted-by":"crossref","first-page":"1159061","DOI":"10.3389\/fimmu.2023.1159061","article-title":"CXCL8 and the peritoneal metastasis of ovarian and gastric cancer","volume":"14","author":"Fu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10637-023-01410-2","article-title":"CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial","volume":"42","author":"Armstrong","year":"2024","journal-title":"Investig. N. Drugs"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2005.10.041","article-title":"Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis","volume":"241","author":"Wente","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118601_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118203","article-title":"Induction of cell death by the CXCR2 antagonist SB225002 in colorectal cancer and stromal cells","volume":"188","author":"Bazzichetto","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"33","key":"10.1016\/j.biopha.2025.118601_bib81","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.2174\/0929867326666191113113110","article-title":"The CXCL12-CXCR4 signaling axis plays a key role in cancer metastasis and is a potential target for developing novel therapeutics against metastatic cancer","volume":"27","author":"Yang","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib82","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.breast.2004.12.007","article-title":"The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer","volume":"14","author":"Kang","year":"2005","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib83","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/1535-7163.MCT-14-0850","article-title":"Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models","volume":"14","author":"Peng","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12935-024-03584-y","article-title":"A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer","volume":"25","author":"Khorramdelazad","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"19","key":"10.1016\/j.biopha.2025.118601_bib85","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.1080\/07391102.2023.2256406","article-title":"Antitumor activities of a novel fluorinated small molecule (A1) in CT26 colorectal cancer cells: molecular docking and in vitro studies","volume":"42","author":"Khorramdelazad","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"14","key":"10.1016\/j.biopha.2025.118601_bib86","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.3390\/ijms22147371","article-title":"CXCL12-CXCR4\/CXCR7 axis in colorectal cancer: therapeutic target in preclinical and clinical studies","volume":"22","author":"Khare","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib87","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3390\/cancers14071810","article-title":"Colorectal cancer: the contribution of CXCL12 and its receptors CXCR4 and CXCR7","volume":"14","author":"Go\u00efta","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118601_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.591386","article-title":"CXCR4 and CXCR7 signaling pathways: a focus on the cross-talk between cancer cells and tumor microenvironment","volume":"11","author":"Santagata","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib89","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40164-023-00460-9","article-title":"Molecular characterization of the CXCR4\/CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugates","volume":"12","author":"Wakileh","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib90","doi-asserted-by":"crossref","first-page":"26985","DOI":"10.1038\/s41598-024-75789-0","article-title":"Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib91","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41388-023-02597-7","article-title":"CXCR7 as a novel therapeutic target for advanced prostate cancer","volume":"42","author":"Gritsina","year":"2023","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.biopha.2025.118601_bib92","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1158\/0008-5472.CAN-06-3424","article-title":"High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer","volume":"67","author":"Hojo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118601_bib93","article-title":"the tumor progression mechanism of increasing cxcl16-cxcr6 pathway within the tumor microenvironment in tnbc. Cancer research","author":"Lee","year":"2024","journal-title":"84(6_Supplement)"},{"key":"10.1016\/j.biopha.2025.118601_bib94","doi-asserted-by":"crossref","first-page":"1022688","DOI":"10.3389\/fonc.2022.1022688","article-title":"The role of CXCR3 and its ligands in cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118601_bib95","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003521","article-title":"Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma","volume":"9","author":"Reschke","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2025.118601_bib96","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2013a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib97","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/cancers15010124","article-title":"EGFR-tyrosine kinase inhibitors induced activation of the autocrine CXCL10\/CXCR3 pathway through crosstalk between the tumor and the microenvironment in EGFR-mutant lung cancer","volume":"15","author":"Hong","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118601_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146962","article-title":"Combination of STING agonist and CXCR3 antagonist disrupts immune tolerance to overcome anti-PD-L1 resistance in lung adenocarcinoma under oxidative stress","volume":"851","author":"Zhu","year":"2023","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcmgh.2021.01.018","article-title":"STING activated tumor-intrinsic type I interferon signaling promotes CXCR3 dependent antitumor immunity in pancreatic cancer","volume":"12","author":"Vonderhaar","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118601_bib100","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.3390\/ijms25094679","article-title":"CX3CL1 (Fractalkine)-CX3CR1 axis in inflammation-induced angiogenesis and tumorigenesis","volume":"25","author":"Szukiewicz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118601_bib101","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.3390\/ijms21103723","article-title":"Fractalkine\/CX3CL1 in neoplastic processes","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.biopha.2025.118601_bib102","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1158\/0008-5472.CAN-08-1810","article-title":"The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma","volume":"68","author":"Marchesi","year":"2008","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.biopha.2025.118601_bib103","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-03-3437","article-title":"CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells","volume":"64","author":"Shulby","year":"2004","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib104","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/1541-7786.MCR-16-0013","article-title":"Novel small-molecule CX3CR1 antagonist impairs metastatic seeding and colonization of breast cancer cells","volume":"14","author":"Shen","year":"2016","journal-title":"Mol. Cancer Res."},{"issue":"22","key":"10.1016\/j.biopha.2025.118601_bib105","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.3390\/cancers16223821","article-title":"A small molecule antagonist of CX3CR1 (KAND567) inhibited the tumor Growth-Promoting effect of monocytes in chronic lymphocytic leukemia (CLL)","volume":"16","author":"Zhong","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib106","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2017.01.003","article-title":"CD8+ t cells orchestrate pDC-XCR1+ dendritic cell spatial and functional cooperativity to optimize priming","volume":"46","author":"Brewitz","year":"2017","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.biopha.2025.118601_bib107","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1038\/s41388-020-1237-0","article-title":"XCL1 expression correlates with CD8-positive t cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary","volume":"39","author":"Tamura","year":"2020","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.biopha.2025.118601_bib108","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-18-0933","article-title":"Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant semliki forest virus\u2013derived vectors fosters dendritic cell\u2013mediated T-cell cross-priming","volume":"78","author":"S\u00e1nchez-Paulete","year":"2018","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib109","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2016.05.032","article-title":"CXCL10\/CXCR3 signaling mobilized-regulatory t cells promote liver tumor recurrence after transplantation","volume":"65","author":"Li","year":"2016","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib110","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.18632\/oncotarget.3205","article-title":"Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration","volume":"6","author":"Zumwalt","year":"2014","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.biopha.2025.118601_bib111","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00262-024-03761-y","article-title":"Tumor-intrinsic IFN\u03b1 and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating t lymphocytes in tumor microenvironment","volume":"73","author":"Cheng","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib112","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41423-018-0187-8","article-title":"CCR2 enhances CD25 expression by FoxP3+ regulatory t cells and regulates their abundance independently of chemotaxis and CCR2+ myeloid cells","volume":"17","author":"Zhan","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib113","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","article-title":"Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ t cell crosspriming in vivo","volume":"24","author":"Le Borgne","year":"2006","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib114","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/polym12112702","article-title":"Fundamental concepts of hydrogels: synthesis, properties, and their applications","volume":"12","author":"Bashir","year":"2020","journal-title":"Polymers"},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib115","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1039\/C1CS15203C","article-title":"Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications","volume":"41","author":"Li","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2025.118601_bib116","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.actbio.2023.10.002","article-title":"Injectable hydrogels for personalized cancer immunotherapies","volume":"172","author":"Mohaghegh","year":"2023","journal-title":"Acta Biomater."},{"issue":"12","key":"10.1016\/j.biopha.2025.118601_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib118","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1039\/D1TB01345A","article-title":"Synthesis, classification and properties of hydrogels: their applications in drug delivery and agriculture","volume":"10","author":"Khan","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib119","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/ma14051095","article-title":"A review on the design and hydration properties of natural polymer-based hydrogels","volume":"14","author":"Karoyo","year":"2021","journal-title":"Materials"},{"issue":"10","key":"10.1016\/j.biopha.2025.118601_bib120","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/pharmaceutics14102028","article-title":"Progress of research in in situ smart hydrogels for local antitumor therapy: a review","volume":"14","author":"Zhao","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.biopha.2025.118601_bib121","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1039\/D4MA00122B","article-title":"Hydrogels as local depots for on-demand therapeutic delivery: potential therapeutic approaches for tumor metastasis","volume":"5","author":"Andrgie","year":"2024","journal-title":"Mater. Adv."},{"key":"10.1016\/j.biopha.2025.118601_bib122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1201\/9781003418252-2","article-title":"Diffusion controlled systems: hydrogels","author":"Korsmeyer","year":"2023","journal-title":"Polym. Control. Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118601_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118085","article-title":"Dextran hydrogels via disulfide-containing schiff base formation: synthesis, stimuli-sensitive degradation and release behaviors","volume":"265","author":"Su","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib124","doi-asserted-by":"crossref","first-page":"2306152","DOI":"10.1002\/advs.202306152","article-title":"Stimulus-Responsive hydrogels as drug delivery systems for inflammation targeted therapy","volume":"11","author":"Yu","year":"2024","journal-title":"Adv. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2025.118601_bib125","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.3390\/molecules28155931","article-title":"Diffusion-limited processes in hydrogels with chosen applications from drug delivery to electronic components","volume":"28","author":"Lavrentev","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00914037.2022.2120875","article-title":"Recent advances in polymeric hydrogel nanoarchitectures for drug delivery applications","volume":"73","author":"Idumah","year":"2024","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"issue":"22","key":"10.1016\/j.biopha.2025.118601_bib127","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1021\/acs.jpcb.2c00771","article-title":"Relationship between gel mesh and particle size in determining nanoparticle diffusion in hydrogel nanocomposites","volume":"126","author":"Moncure","year":"2022","journal-title":"J. Phys. Chem. B"},{"issue":"18","key":"10.1016\/j.biopha.2025.118601_bib128","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1021\/acs.macromol.9b00753","article-title":"A multiscale model for solute diffusion in hydrogels","volume":"52","author":"Axpe","year":"2019","journal-title":"Macromolecules"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib129","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1039\/D1SM01456K","article-title":"Defect-controlled softness, diffusive permeability, and mesh-topology of metallo-supramolecular hydrogels","volume":"18","author":"Nicolella","year":"2022","journal-title":"Soft Matter"},{"issue":"16","key":"10.1016\/j.biopha.2025.118601_bib130","doi-asserted-by":"crossref","first-page":"2100076","DOI":"10.1002\/macp.202100076","article-title":"Reversible hydrogels with switchable diffusive permeability","volume":"222","author":"Nicolella","year":"2021","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.biopha.2025.118601_bib131","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1002027","article-title":"Physiochemical and biomedical properties of hydrogels: from fundamentals to applications","author":"Varghese","year":"2024","journal-title":"Hydrogels NanogelsAppl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib132","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pi.1697","article-title":"Factors affecting the degradation and drug-release mechanism of poly (lactic acid) and poly [(lactic acid)-co-(glycolic acid)].","volume":"54","author":"Alexis","year":"2005","journal-title":"Polym. Int."},{"key":"10.1016\/j.biopha.2025.118601_bib133","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2018.08.002","article-title":"Degradable poly (ethylene glycol)(PEG)-based hydrogels for spatiotemporal control of siRNA\/nanoparticle delivery","volume":"287","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib134","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3109\/10717544.2014.940091","article-title":"Stimuli-responsive hydrogels in drug delivery and tissue engineering","volume":"23","author":"Sood","year":"2016","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib135","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1039\/D0QM00868K","article-title":"Stimuli-responsive conductive hydrogels: design, properties, and applications","volume":"5","author":"Deng","year":"2021","journal-title":"Mater. Chem. Front."},{"key":"10.1016\/j.biopha.2025.118601_bib136","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijbiomac.2022.01.022","article-title":"Modified chitosan-hyaluronic acid based hydrogel for the pH-responsive Co-delivery of cisplatin and doxorubicin","volume":"201","author":"Anirudhan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib137","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0971-6866.112870","article-title":"Delivery systems for gene therapy","volume":"19","author":"Mali","year":"2013","journal-title":"Indian J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib138","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41563-023-01472-w","article-title":"Hydrogels for RNA delivery","volume":"22","author":"Zhong","year":"2023","journal-title":"Nat. Mater."},{"issue":"30","key":"10.1016\/j.biopha.2025.118601_bib139","doi-asserted-by":"crossref","first-page":"2401895","DOI":"10.1002\/adhm.202401895","article-title":"Hydrogels for nucleic acid drugs delivery","volume":"13","author":"Liu","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.118601_bib140","doi-asserted-by":"crossref","first-page":"1598145","DOI":"10.3389\/fddev.2025.1598145","article-title":"Gene hydrogel platforms for targeted skin therapy: bridging hereditary disorders, chronic wounds, and immune related skin diseases","volume":"5","author":"Li","year":"2025","journal-title":"Front. Drug Deliv."},{"issue":"17","key":"10.1016\/j.biopha.2025.118601_bib141","doi-asserted-by":"crossref","first-page":"2206306","DOI":"10.1002\/advs.202206306","article-title":"High-performance multi-dynamic bond cross-linked hydrogel with spatiotemporal siRNA delivery for gene\u2013cell combination therapy of intervertebral disc degeneration","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.118601_bib142","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejps.2019.03.021","article-title":"Novel facile thermosensitive hydrogel as sustained and controllable gene release vehicle for breast cancer treatment","volume":"134","author":"Zhao","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib143","doi-asserted-by":"crossref","first-page":"1801987","DOI":"10.1002\/advs.201801987","article-title":"Redox-responsive dual drug delivery nanosystem suppresses cancer repopulation by abrogating doxorubicin-promoted cancer stemness, metastasis, and drug resistance","volume":"6","author":"Liu","year":"2019","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib144","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/la1037553","article-title":"Photoresponsive DNA-cross-linked hydrogels for controllable release and cancer therapy","volume":"27","author":"Kang","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.biopha.2025.118601_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121931","article-title":"Oxidized cellulose-filled double thermo\/pH-sensitive hydrogel for local chemo-photothermal therapy in breast cancer","volume":"332","author":"Zhang","year":"2024","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib146","first-page":"373","article-title":"Hydrogel-based controlled drug delivery for cancer treatment: a review","volume":"17","author":"Sun","year":"2019","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib147","doi-asserted-by":"crossref","first-page":"2001341","DOI":"10.1002\/adhm.202001341","article-title":"Recent advances in injectable hydrogels for controlled and local drug delivery","volume":"10","author":"Rizzo","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"9","key":"10.1016\/j.biopha.2025.118601_bib148","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/pharmaceutics11090486","article-title":"Injectable hydrogels for cancer therapy over the last decade","volume":"11","author":"Cirillo","year":"2019","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib149","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/pharmaceutics13111953","article-title":"Advances in injectable in situ-forming hydrogels for intratumoral treatment","volume":"13","author":"Shin","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118601_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112026","article-title":"An intratumoral injectable nanozyme hydrogel for hypoxia-resistant thermoradiotherapy","volume":"207","author":"Wang","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2025.118601_bib151","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.biomaterials.2016.02.001","article-title":"Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot","volume":"85","author":"Kwon","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib152","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1080\/10717544.2022.2111480","article-title":"Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma","volume":"29","author":"Xiao","year":"2022","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib153","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1021\/acsami.2c18494","article-title":"Implantable 3D printed hydrogel scaffolds loading copper-doxorubicin complexes for postoperative chemo\/chemodynamic therapy","volume":"15","author":"Dang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib154","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/gels9050352","article-title":"Gel formulations for topical treatment of skin cancer: a review","volume":"9","author":"Slavkova","year":"2023","journal-title":"Gels"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib155","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.3390\/pharmaceutics15112577","article-title":"Innovative topical patches for non-melanoma skin cancer: current challenges and key formulation considerations","volume":"15","author":"Kim","year":"2023","journal-title":"Pharmaceutics"},{"issue":"22","key":"10.1016\/j.biopha.2025.118601_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202200740","article-title":"Application of hydrogels as carrier in tumor therapy: a review","volume":"17","author":"Zhang","year":"2022","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.biopha.2025.118601_bib157","series-title":"in Hydrogels based on natural polymers","first-page":"17","article-title":"Natural polymers and the hydrogels prepared from them","author":"Varghese","year":"2020"},{"issue":"10","key":"10.1016\/j.biopha.2025.118601_bib158","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/ph17101260","article-title":"Advances in chitosan-based smart hydrogels for colorectal cancer treatment","volume":"17","author":"Piotrowska","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118601_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.142283","article-title":"An injectable and rapidly degraded carboxymethyl chitosan\/polyethylene glycol hydrogel for postoperative antiadhesion","volume":"463","author":"Wang","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biopha.2025.118601_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117779","article-title":"Tunable porosity of covalently crosslinked alginate-based hydrogels and its significance in drug release behavior","volume":"260","author":"Siboro","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2025.118601_bib161","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.actbio.2016.04.032","article-title":"An alginate-based platform for cancer stem cell research","volume":"37","author":"Qiao","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2025.118601_bib162","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejpb.2017.06.028","article-title":"Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy","volume":"119","author":"Ferreira","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib163","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/acs.biomac.3c01021","article-title":"Chemical and structural engineering of gelatin-based delivery systems for therapeutic applications: a review","volume":"25","author":"Jia","year":"2024","journal-title":"Biomacromolecules"},{"issue":"30","key":"10.1016\/j.biopha.2025.118601_bib164","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1039\/D3TB00478C","article-title":"Nanocellulose-based hydrogels for drug delivery","volume":"11","author":"Ai","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"23","key":"10.1016\/j.biopha.2025.118601_bib165","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.3390\/nano12234288","article-title":"Dynamic light scattering plus scanning electron microscopy: usefulness and limitations of a simplified estimation of nanocellulose dimensions","volume":"12","author":"Tarr\u00e9s","year":"2022","journal-title":"Nanomaterials"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib166","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1021\/acsapm.2c01188","article-title":"Gelatin-based injectable hydrogel\/microgel composite as a combinational dual drug delivery system for local co-delivery of curcumin and 5-fluorouracil in synergistic therapy of colorectal cancer","volume":"4","author":"Pakian","year":"2022","journal-title":"ACS Appl. Polym. Mater."},{"issue":"19","key":"10.1016\/j.biopha.2025.118601_bib167","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1039\/D1BM00854D","article-title":"The effect of polysaccharide-based hydrogels on the response of antigen-presenting cell lines to immunomodulators","volume":"9","author":"Chung","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2025.118601_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.152032","article-title":"Plant-Derived Exosome-Like Nanovesicles-Created injectable hydrogel for augmented cancer immunotherapy","volume":"491","author":"Yang","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib169","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejpb.2014.07.005","article-title":"Polyethylene glycol (PEG)\u2013Poly (N-isopropylacrylamide)(PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications","volume":"88","author":"Alexander","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13233-016-4052-2","article-title":"Snapshot of phase transition in thermoresponsive hydrogel PNIPAM: role in drug delivery and tissue engineering","volume":"24","author":"Ashraf","year":"2016","journal-title":"Macromol. Res."},{"key":"10.1016\/j.biopha.2025.118601_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111694","article-title":"A novel \u2018smart\u2019PNIPAM-based copolymer for breast cancer targeted therapy: synthesis, and characterization of dual pH\/temperature-responsive lactoferrin-targeted PNIPAM-co-AA","volume":"202","author":"Metawea","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"18","key":"10.1016\/j.biopha.2025.118601_bib172","doi-asserted-by":"crossref","first-page":"2300105","DOI":"10.1002\/adhm.202300105","article-title":"Poly ethylene glycol (PEG)-based hydrogels for drug delivery in cancer therapy: a comprehensive review","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib173","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12951-024-02468-7","article-title":"A lava-inspired proteolytic enzyme therapy on cancer with a PEG-based hydrogel enhances tumor distribution and penetration of liposomes","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnology"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib174","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1021\/acsbiomaterials.9b00480","article-title":"Evaluation of PEG-based hydrogel influence on estrogen-receptor-driven responses in MCF7 breast cancer cells","volume":"5","author":"Livingston","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib175","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/molecules25071539","article-title":"New developments in medical applications of hybrid hydrogels containing natural polymers","volume":"25","author":"Vasile","year":"2020","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib176","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1021\/acsanm.9b01924","article-title":"Hybrid hydrogel composed of carboxymethylcellulose\u2013silver nanoparticles\u2013doxorubicin for anticancer and antibacterial therapies against melanoma skin cancer cells","volume":"2","author":"Capanema","year":"2019","journal-title":"ACS Appl. Nano Mater."},{"issue":"10","key":"10.1016\/j.biopha.2025.118601_bib177","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.7150\/thno.38069","article-title":"Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics","volume":"10","author":"Mi","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib178","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/jfb10030034","article-title":"Stimuli-responsive drug release from smart polymers","volume":"10","author":"Wells","year":"2019","journal-title":"J. Funct. Biomater."},{"issue":"49","key":"10.1016\/j.biopha.2025.118601_bib179","doi-asserted-by":"crossref","first-page":"2005029","DOI":"10.1002\/adfm.202005029","article-title":"Light: a magical tool for controlled drug delivery","volume":"30","author":"Tao","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"31","key":"10.1016\/j.biopha.2025.118601_bib180","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1021\/acsnano.4c04067","article-title":"Stimuli-Responsive hydrogels potentiating photothermal therapy against cancer stem Cell\u2013Induced breast cancer metastasis","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2025.118601_bib181","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.actbio.2017.06.001","article-title":"pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy","volume":"58","author":"Qu","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2025.118601_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140748","article-title":"Synthesis of magnetic bio-nanocomposite hydrogel beads based on sodium alginate and \u03b2-cyclodextrin: potential pH-responsive oral delivery anticancer systems for colorectal cancer","volume":"305","author":"Tahmasebi","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118601_bib183","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.colsurfb.2018.05.002","article-title":"Rheological behavior of ph responsive composite hydrogels of chitosan and alginate: characterization and its use in encapsulation of citral","volume":"169","author":"Afzal","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib184","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1039\/C9BM00139E","article-title":"Paclitaxel-loaded ph responsive hydrogel based on self-assembled peptides for tumor targeting","volume":"7","author":"Raza","year":"2019","journal-title":"Biomater. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2025.118601_bib185","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1039\/D0TB02877K","article-title":"Recent advances in thermo-sensitive hydrogels for drug delivery","volume":"9","author":"Yu","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib186","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1021\/acsabm.1c00046","article-title":"Thermoresponsive and injectable composite hydrogels of cellulose nanocrystals and pluronic F127","volume":"4","author":"Kushan","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib187","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/acs.biomac.2c01380","article-title":"Thermosensitive PNIPAM-based hydrogel crosslinked by composite nanoparticles as rapid wound-healing dressings","volume":"24","author":"Hu","year":"2023","journal-title":"Biomacromolecules"},{"issue":"38","key":"10.1016\/j.biopha.2025.118601_bib188","doi-asserted-by":"crossref","first-page":"42812","DOI":"10.1021\/acsami.2c05864","article-title":"Cellulose nanocrystals-incorporated thermosensitive hydrogel for controlled release, 3D printing, and breast cancer treatment applications","volume":"14","author":"Phan","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.biopha.2025.118601_bib189","first-page":"001","article-title":"Temperature and pH-responsive nanogels as intelligent drug delivery systems: a comprehensive review","volume":"11","author":"Jha","year":"2021","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118601_bib190","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jconrel.2022.07.011","article-title":"Dual-sensitive drug-loaded hydrogel system for local inhibition of post-surgical glioma recurrence","volume":"349","author":"Chen","year":"2022","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib191","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1021\/acsnano.5b01433","article-title":"Nanocomposite hydrogels: 3D polymer\u2013nanoparticle synergies for on-demand drug delivery","volume":"9","author":"Merino","year":"2015","journal-title":"ACS nano"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib192","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/pharmaceutics15020319","article-title":"18F-fluorodeoxyglucose (18F-FDG) functionalized gold nanoparticles (GNPs) for plasmonic photothermal ablation of cancer: a review","volume":"15","author":"Pontico","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118601_bib193","doi-asserted-by":"crossref","first-page":"1045612","DOI":"10.3389\/fchem.2022.1045612","article-title":"Injectable agarose hydrogels and doxorubicin-encapsulated iron-gallic acid nanoparticles for chemodynamic-photothermal synergistic therapy against osteosarcoma","volume":"10","author":"Ying","year":"2022","journal-title":"Front. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2025.118601_bib194","doi-asserted-by":"crossref","first-page":"2313188","DOI":"10.1002\/adma.202313188","article-title":"Engineered bio-based hydrogels for cancer immunotherapy","volume":"36","author":"Peng","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib195","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1186\/s12967-024-05490-3","article-title":"Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy","volume":"22","author":"Zang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"19","key":"10.1016\/j.biopha.2025.118601_bib196","doi-asserted-by":"crossref","first-page":"21441","DOI":"10.1021\/acsami.0c03360","article-title":"Injectable drug-conjugated DNA hydrogel for local chemotherapy to prevent tumor recurrence","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib197","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1039\/D4MH00981A","article-title":"Targeted and precise drug delivery using a glutathione-responsive ultra-short peptide-based injectable hydrogel as a breast cancer cure","volume":"12","author":"Halder","year":"2025","journal-title":"Mater. Horiz."},{"issue":"18","key":"10.1016\/j.biopha.2025.118601_bib198","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.biomaterials.2014.03.001","article-title":"Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.118601_bib199","first-page":"326","article-title":"Cryo-shocked cancer cell microgels for tumor postoperative combination immunotherapy and tissue regeneration","volume":"28","author":"Kuang","year":"2023","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib200","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/molecules26040873","article-title":"Supramolecular hydrogels for protein delivery in tissue engineering","volume":"26","author":"Lyu","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib201","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tips.2021.01.005","article-title":"Affinity hydrogels for protein delivery","volume":"42","author":"Abune","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"18","key":"10.1016\/j.biopha.2025.118601_bib202","doi-asserted-by":"crossref","first-page":"2100293","DOI":"10.1002\/advs.202100293","article-title":"Chemokine-capturing wound contact layer rescues dermal healing","volume":"8","author":"Schirmer","year":"2021","journal-title":"Adv. Sci."},{"issue":"45","key":"10.1016\/j.biopha.2025.118601_bib203","doi-asserted-by":"crossref","first-page":"2004098","DOI":"10.1002\/adfm.202004098","article-title":"Potential applications of advanced nano\/hydrogels in biomedicine: static, dynamic, multi-stage, and bioinspired","volume":"30","author":"Ayoubi-Joshaghani","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2025.118601_bib204","doi-asserted-by":"crossref","first-page":"1018962","DOI":"10.3389\/fimmu.2022.1018962","article-title":"Tumor-infiltrating lymphocytes for treatment of solid tumors: it takes two to tango?","volume":"13","author":"Kazemi","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10555-021-09970-6","article-title":"Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity","volume":"40","author":"Saxena","year":"2021","journal-title":"Cancer Metastas.. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib206","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10753-020-01235-8","article-title":"The complexity of targeting chemokines to promote a tumor immune response","volume":"43","author":"Strazza","year":"2020","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2019.1701141","article-title":"Neutrophils, as \"trojan horses\", participate in the delivery of therapeutical PLGA nanoparticles into a tumor based on the chemotactic effect","volume":"27","author":"Hao","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118601_bib208","first-page":"331","article-title":"Tumor associated macrophages as therapeutic targets for breast cancer","author":"Lao","year":"2017","journal-title":"Translational Research Breast Cancer Biomarker Diagnosis Targeted Therapies Approaches Precision Medicine"},{"key":"10.1016\/j.biopha.2025.118601_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.111435","article-title":"Natural small molecule self-assembled hydrogel inhibited tumor growth and lung metastasis of 4T1 breast cancer by regulating the CXCL1\/2-S100A8\/9 axis","volume":"225","author":"Yang","year":"2023","journal-title":"Mater. Des."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1073\/pnas.0808932106","article-title":"Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement","volume":"106","author":"Fischbach","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118601_bib211","article-title":"University of Southern california","author":"Sharda","year":"2012","journal-title":"Block CXCR2 a Nov. Approach Cancer Chemother."},{"key":"10.1016\/j.biopha.2025.118601_bib212","doi-asserted-by":"crossref","first-page":"2401161","DOI":"10.1002\/adfm.202401161","article-title":"Chemokine-Based injectable navigation system for enhancing CAR-T cell therapy against solid tumors","author":"Wan","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib213","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1074374","article-title":"Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity","volume":"5","author":"Li","year":"2016","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib214","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib215","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41565-020-00843-7","article-title":"Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection","volume":"16","author":"Zhang","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.118601_bib216","first-page":"236","article-title":"Preventing postsurgical colorectal cancer relapse: a hemostatic hydrogel loaded with METTL3 inhibitor for CAR-NK cell therapy","volume":"44","author":"Tan","year":"2025","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib217","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 inhibits antitumor immunity by targeting m6A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib218","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.chembiol.2023.09.001","article-title":"Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy","volume":"31","author":"Yu","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib219","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1039\/D3NH00401E","article-title":"Hydrogel-mediated tumor t cell infiltration and immune evasion to reinforce cancer immunotherapy","volume":"9","author":"Xu","year":"2024","journal-title":"Nanoscale Horiz."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib220","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acs.biomac.5b00144","article-title":"Sustained delivery of chemokine CXCL12 from chemically modified silk hydrogels","volume":"16","author":"Atterberry","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biopha.2025.118601_bib221","doi-asserted-by":"crossref","first-page":"249","DOI":"10.22203\/eCM.v023a19","article-title":"Mesenchymal stem cell recruitment by stromal derived factor-1-delivery systems based on chitosan\/poly (gamma-glutamic acid) polyelectrolyte complexes","volume":"23","author":"Gon\u00e7alves","year":"2012","journal-title":"Eur. Cell Mater."},{"issue":"38","key":"10.1016\/j.biopha.2025.118601_bib222","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1016\/j.biomaterials.2013.08.082","article-title":"Human progenitor cell recruitment via SDF-1\u03b1 coacervate-laden PGS vascular grafts","volume":"34","author":"Lee","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib223","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2012.04.049","article-title":"A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro","volume":"162","author":"Baumann","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib224","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.12-221515","article-title":"Chemotactic recruitment of adult neural progenitor cells into multifunctional hydrogels providing sustained SDF-1\u03b1 release and compatible structural support","volume":"27","author":"Lim","year":"2013","journal-title":"FASEB J."},{"issue":"27","key":"10.1016\/j.biopha.2025.118601_bib225","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1016\/j.biomaterials.2013.05.014","article-title":"Surface-engineering of glycidyl methacrylated dextran\/gelatin microcapsules with thermo-responsive poly (N-isopropylacrylamide) gates for controlled delivery of stromal cell-derived factor-1\u03b1","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib226","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.actbio.2011.12.009","article-title":"Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan\/tripolyphosphate\/fucoidan nanoparticles","volume":"8","author":"Huang","year":"2012","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib227","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2007.08.048","article-title":"Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1-and HGF-dependent manner","volume":"426","author":"Takeuchi","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib228","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1365-2133.2007.08240.x","article-title":"Biphasic expression of stromal cell-derived factor-1 during human wound healing","volume":"157","author":"Toksoy","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib229","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10147-017-1187-x","article-title":"Biological\/pathological functions of the CXCL12\/CXCR4\/CXCR7 axes in the pathogenesis of bladder cancer","volume":"22","author":"Nazari","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12032-025-02705-5","article-title":"CXCR4\/CXCL12 blockade therapy; a new horizon in TNBC therapy","volume":"42","author":"Khaleel","year":"2025","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib231","first-page":"49","article-title":"CXCL12 as a metastasis inducer chemokine of breast cancer","volume":"27","author":"Altimmime","year":"2024","journal-title":"AlNahrain J. Sci."},{"key":"10.1016\/j.biopha.2025.118601_bib232","doi-asserted-by":"crossref","first-page":"1646006","DOI":"10.3389\/fphar.2025.1646006","article-title":"Correction: mechanism underlying the involvement of CXCR4\/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib233","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/pharmaceutics14081541","article-title":"Recent advances in CXCL12\/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy","volume":"14","author":"Zhao","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118601_bib234","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jconrel.2025.01.066","article-title":"CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma","volume":"379","author":"Cheng","year":"2025","journal-title":"J. Control. Release"},{"issue":"14","key":"10.1016\/j.biopha.2025.118601_bib235","doi-asserted-by":"crossref","first-page":"2300671","DOI":"10.1002\/adhm.202300671","article-title":"Development of a synthetic, injectable hydrogel to capture residual glioblastoma and glioblastoma Stem-Like cells with CXCL12-Mediated chemotaxis","volume":"12","author":"Khan","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.118601_bib236","series-title":"in Seminars in cancer biology","article-title":"The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis","author":"Li","year":"2009"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib237","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/14728222.2024.2433130","article-title":"Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targets","volume":"28","author":"Corsaro","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2025.118601_bib238","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.actbio.2014.11.033","article-title":"Surface-templated hydrogel patterns prompt matrix-dependent migration of breast cancer cells towards chemokine-secreting cells","volume":"13","author":"Kojima","year":"2015","journal-title":"Acta Biomater."},{"issue":"12","key":"10.1016\/j.biopha.2025.118601_bib239","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/bios12121177","article-title":"On-chip organoid formation to study CXCR4\/CXCL-12 chemokine microenvironment responses for renal cancer drug testing","volume":"12","author":"Ozcelik","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.biopha.2025.118601_bib240","doi-asserted-by":"crossref","first-page":"1227776","DOI":"10.3389\/fddev.2023.1227776","article-title":"Impact of simulated brain interstitial fluid flow on the chemokine CXCL12 release from an alginate-based hydrogel in a new 3D in vitro model","volume":"3","author":"El Kheir","year":"2023","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118601_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125570","article-title":"Alginate gels: chemistry, gelation mechanisms, and therapeutic applications with a focus on GERD treatment","author":"Kapoor","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib242","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/md20060364","article-title":"Structures, properties and applications of alginates","volume":"20","author":"Abka-Khajouei","year":"2022","journal-title":"Mar. Drugs"},{"issue":"22","key":"10.1016\/j.biopha.2025.118601_bib243","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1021\/acs.nanolett.2c01994","article-title":"Injectable immunotherapeutic hydrogel containing RNA-Loaded lipid nanoparticles reshapes tumor microenvironment for pancreatic cancer therapy","volume":"22","author":"Gao","year":"2022","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib244","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1189\/jlb.3MA0815-373R","article-title":"Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors","volume":"99","author":"Weitzenfeld","year":"2016","journal-title":"J. Leucoc. Biol."},{"issue":"19","key":"10.1016\/j.biopha.2025.118601_bib245","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1021\/acs.nanolett.4c01267","article-title":"Sustained secretion of CCL21 via an implantable cell reservoir hydrogel enhances the systemic antitumor effect of radiotherapy","volume":"24","author":"Gao","year":"2024","journal-title":"Nano Lett."},{"issue":"22","key":"10.1016\/j.biopha.2025.118601_bib246","article-title":"Modular hydrogel vaccine for programmable and coordinate elicitation of cancer immunotherapy","volume":"10","author":"Ji","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"47","key":"10.1016\/j.biopha.2025.118601_bib247","doi-asserted-by":"crossref","first-page":"2309667","DOI":"10.1002\/adma.202309667","article-title":"Promoting the recruitment, engagement, and reinvigoration of effector t cells via an injectable hydrogel with a supramolecular binding capability for cancer immunotherapy","volume":"35","author":"Zhu","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib248","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40824-018-0138-6","article-title":"Injectable hydrogels delivering therapeutic agents for disease treatment and tissue engineering","volume":"22","author":"Lee","year":"2018","journal-title":"Biomater. Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib249","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10158","article-title":"Hydrogels in the clinic","volume":"5","author":"Mandal","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118601_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.115832","article-title":"Modularly engineered alginate bioconjugate hydrogel as biocompatible injectable scaffold for in situ biomineralization","volume":"233","author":"Kim","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2025.118601_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.110180","article-title":"POSS hybrid hydrogels: a brief review of synthesis, properties and applications","volume":"143","author":"Liu","year":"2021","journal-title":"Eur. Polym. J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib252","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C1SM06513K","article-title":"Shear-thinning hydrogels for biomedical applications","volume":"8","author":"Guvendiren","year":"2012","journal-title":"Soft Matter"},{"issue":"24","key":"10.1016\/j.biopha.2025.118601_bib253","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1039\/C9TB00485H","article-title":"Recent advances in the design of injectable hydrogels for stem cell-based therapy","volume":"7","author":"Liang","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib254","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1039\/b713009k","article-title":"Injectable hydrogels as unique biomedical materials","volume":"37","author":"Yu","year":"2008","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib255","doi-asserted-by":"crossref","first-page":"1902785","DOI":"10.1002\/adfm.201902785","article-title":"Smart injectable hydrogels for cancer immunotherapy","volume":"30","author":"Chao","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2025.118601_bib256","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2017.04.009","article-title":"Bioengineered robust hybrid hydrogels enrich the stability and efficacy of biological drugs","volume":"267","author":"Gil","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118601_bib257","series-title":"Rheological characterization of hydrogels. Polysaccharide Hydrogels: Characterization and Biomedical Applications","first-page":"83","author":"Lapasin","year":"2015"},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib258","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/gels7040255","article-title":"Relationship between structure and rheology of hydrogels for various applications","volume":"7","author":"Stojkov","year":"2021","journal-title":"Gels"},{"issue":"18","key":"10.1016\/j.biopha.2025.118601_bib259","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1021\/acs.chemrev.0c01177","article-title":"Translational applications of hydrogels","volume":"121","author":"Correa","year":"2021","journal-title":"Chem. Rev."},{"issue":"12-13","key":"10.1016\/j.biopha.2025.118601_bib260","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.addr.2006.09.004","article-title":"Hydrogels in controlled release formulations: network design and mathematical modeling","volume":"58","author":"Lin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118601_bib261","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.actbio.2016.04.030","article-title":"Cell recruiting chemokine-loaded sprayable gelatin hydrogel dressings for diabetic wound healing","volume":"38","author":"Yoon","year":"2016","journal-title":"Acta Biomater."},{"issue":"29","key":"10.1016\/j.biopha.2025.118601_bib262","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1039\/c2sm25677k","article-title":"Mesh size distribution determination of interpenetrating polymer network hydrogels","volume":"8","author":"Pescosolido","year":"2012","journal-title":"Soft Matter"},{"issue":"36","key":"10.1016\/j.biopha.2025.118601_bib263","doi-asserted-by":"crossref","first-page":"30103","DOI":"10.1021\/acsami.8b09191","article-title":"Bioactive injectable hydrogels containing desferrioxamine and bioglass for diabetic wound healing","volume":"10","author":"Kong","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.118601_bib264","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2017.07.013","article-title":"Enrichment of endogenous fractalkine and anti-inflammatory cells via aptamer-functionalized hydrogels","volume":"142","author":"Enam","year":"2017","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib265","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1021\/cr200157d","article-title":"Hydrogels for protein delivery","volume":"112","author":"Vermonden","year":"2012","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib266","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jps.20209","article-title":"Uniform encapsulation of stable protein nanoparticles produced by spray freezing for the reduction of burst release","volume":"94","author":"Leach","year":"2005","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib267","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.7150\/thno.30577","article-title":"Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy","volume":"9","author":"Song","year":"2019","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib268","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00289-018-2417-8","article-title":"Optical properties of PVC\/Al2O3 nanocomposite films","volume":"76","author":"Taha","year":"2019","journal-title":"Polym. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib269","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.reactfunctpolym.2004.07.002","article-title":"Synthesis and characterization of novel gels based on carboxymethyl cellulose\/acrylic acid prepared by electron beam irradiation","volume":"61","author":"Said","year":"2004","journal-title":"React. Funct. Polym."},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib270","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1021\/acsmacrolett.9b00475","article-title":"Step-growth polymerization method for ultrahigh molecular weight polymers","volume":"8","author":"Zhang","year":"2019","journal-title":"ACS Macro Lett."},{"issue":"40","key":"10.1016\/j.biopha.2025.118601_bib271","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1021\/acsnano.4c09190","article-title":"Tumor Microenvironment-Derived exosomes: a double-edged sword for advanced t cell-based immunotherapy","volume":"18","author":"Lu","year":"2024","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2025.118601_bib272","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fbioe.2020.00627","article-title":"Cell membrane-based biomimetic nanoparticles and the immune system: immunomodulatory interactions to therapeutic applications","volume":"8","author":"Sushnitha","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"35","key":"10.1016\/j.biopha.2025.118601_bib273","doi-asserted-by":"crossref","first-page":"1701429","DOI":"10.1002\/adma.201701429","article-title":"Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy","volume":"29","author":"Gao","year":"2017","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.biopha.2025.118601_bib274","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.3390\/pharmaceutics15122770","article-title":"Cell membrane biomimetic nano-delivery systems for cancer therapy","volume":"15","author":"Xia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118601_bib275","doi-asserted-by":"crossref","first-page":"rbac009","DOI":"10.1093\/rb\/rbac009","article-title":"Rational design of hydrogels for immunomodulation","volume":"9","author":"Bu","year":"2022","journal-title":"Regen. Biomater."},{"issue":"28","key":"10.1016\/j.biopha.2025.118601_bib276","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib277","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00018-014-1738-5","article-title":"Microscale screening systems for 3D cellular microenvironments: platforms, advances, and challenges","volume":"72","author":"Montanez-Sauri","year":"2015","journal-title":"Cell. Mol. life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118601_bib278","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/ph15030371","article-title":"Current and future prospective of injectable hydrogels\u2014design challenges and limitations","volume":"15","author":"Almawash","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib279","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/10717544.2020.1739171","article-title":"Research progress in the application of in situ hydrogel system in tumor treatment","volume":"27","author":"Wei","year":"2020","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib280","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1016\/j.prro.2023.11.011","article-title":"A multi-institutional safety and feasibility study exploring the use of hydrogel to create spatial separation between the pancreas and duodenum in patients with pancreatic cancer","volume":"14","author":"Narang","year":"2024","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.biopha.2025.118601_bib281","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","article-title":"Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy","volume":"10","author":"Vilgelm","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib282","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/nn300842a","article-title":"Injectable polyplex hydrogel for localized and long-term delivery of siRNA","volume":"6","author":"Kim","year":"2012","journal-title":"ACS nano"},{"issue":"30","key":"10.1016\/j.biopha.2025.118601_bib283","doi-asserted-by":"crossref","first-page":"39784","DOI":"10.1021\/acsami.4c05425","article-title":"Transforming cell\u2013drug interaction through granular hydrogel-mediated delivery of polyplex nanoparticles for enhanced safety and extended efficacy in gene therapy","volume":"16","author":"Zhang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.118601_bib284","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.2147\/IJN.S180859","article-title":"Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2","author":"Wang","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.biopha.2025.118601_bib285","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.actbio.2008.11.019","article-title":"Modular injectable matrices based on alginate solution\/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors","volume":"5","author":"Hori","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2025.118601_bib286","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109220","article-title":"Environment sensitive hydrogels for drug delivery applications","volume":"120","author":"Qureshi","year":"2019","journal-title":"Eur. Polym. J."},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib287","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97828","article-title":"CX3CR1 identifies PD-1 therapy\u2013responsive CD8+ t cells that withstand chemotherapy during cancer chemoimmunotherapy","volume":"3","author":"Yan","year":"2018","journal-title":"JCI Insight"},{"issue":"44","key":"10.1016\/j.biopha.2025.118601_bib288","doi-asserted-by":"crossref","first-page":"2404941","DOI":"10.1002\/adfm.202404941","article-title":"An ultrasound-responsive and in situ gelling hydrogel nanocomposite for boosting anti PD-L1 immunotherapy via remodeling aberrant ECM of post-surgical residual cancer","volume":"34","author":"Cao","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib289","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41467-022-29388-0","article-title":"Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2025.118601_bib290","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009543","article-title":"Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8+ CD69+ t cells","volume":"12","author":"Tang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2025.118601_bib291","article-title":"Smart Energy-Storing DNA hydrogel for On-Demand Laser-Free photoimmunotherapy of melanoma","author":"Zhao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2025.118601_bib292","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jconrel.2020.12.040","article-title":"Melanin-loaded CpG DNA hydrogel for modulation of tumor immune microenvironment","volume":"330","author":"Wu","year":"2021","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib293","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3390\/gels11060426","article-title":"Multifunctional hydrogels for advanced cancer treatment: diagnostic imaging and therapeutic modalities","volume":"11","author":"Lee","year":"2025","journal-title":"Gels"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib294","doi-asserted-by":"crossref","first-page":"2406439","DOI":"10.1002\/smll.202406439","article-title":"Engineering Stimuli-Responsive materials for precision Medicine","volume":"21","author":"Zheng","year":"2025","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.biopha.2025.118601_bib295","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1039\/D0CS00384K","article-title":"Radiolabelling of nanomaterials for medical imaging and therapy","volume":"50","author":"Pellico","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2025.118601_bib296","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20220173","article-title":"Gel\/hydrogel-based in situ biomaterial platforms for cancer postoperative treatment and recovery","author":"Feng","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.biopha.2025.118601_bib297","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biomac.4c01816","article-title":"3D bioprinted Immunomodulation\u2500 the advancing landscape of Next-Generation Immuno-oncology","author":"Debnath","year":"2025","journal-title":"Biomacromolecules"},{"issue":"19","key":"10.1016\/j.biopha.2025.118601_bib298","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.2174\/092986712800784658","article-title":"Polysaccharide-based nanoparticles: a versatile platform for drug delivery and biomedical imaging","volume":"19","author":"Saravanakumar","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118601_bib299","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/acsbiomaterials.1c01631","article-title":"Polysaccharide-based theranostic systems for combined imaging and cancer therapy: recent advances and challenges","volume":"8","author":"Gupta","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"44","key":"10.1016\/j.biopha.2025.118601_bib300","doi-asserted-by":"crossref","first-page":"49582","DOI":"10.1021\/acsami.2c15428","article-title":"Injectable carbon dots-based hydrogel for combined photothermal therapy and photodynamic therapy of cancer","volume":"14","author":"Yue","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.118601_bib301","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.143685","article-title":"Combined photothermal and photodynamic therapy enhances ferroptosis to prevent cancer recurrence after surgery using nanoparticle-hydrogel composite","volume":"468","author":"Chen","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biopha.2025.118601_bib302","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.urology.2020.10.023","article-title":"Utilizing 3D printing and hydrogel casting for the development of patient-specific rehearsal platforms for robotic assisted partial nephrectomies","volume":"147","author":"Ghazi","year":"2021","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib303","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/pharmaceutics17020215","article-title":"Hydrogels and nanogels: pioneering the future of advanced drug delivery systems","volume":"17","author":"Delgado-Pujol","year":"2025","journal-title":"Pharmaceutics"},{"issue":"20","key":"10.1016\/j.biopha.2025.118601_bib304","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.3390\/ijms222011300","article-title":"Stimulus-responsive smart nanoparticles-based CRISPR-cas delivery for therapeutic genome editing","volume":"22","author":"Naeem","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118601_bib305","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101477","article-title":"Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids","volume":"24","author":"Suraiya","year":"2022","journal-title":"Transl. Oncol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118601_bib306","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.3390\/ijms22189804","article-title":"Chemokine-directed tumor microenvironment modulation in cancer immunotherapy","volume":"22","author":"Bule","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118601_bib307","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2147\/DDDT.S217211","article-title":"Hydrogels for peptide hormones delivery: therapeutic and tissue engineering applications","author":"Doostmohammadi","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2025.118601_bib308","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.carbpol.2017.03.014","article-title":"Carboxymethyl cellulose\/graphene oxide bio-nanocomposite hydrogel beads as anticancer drug carrier agent","volume":"168","author":"Rasoulzadeh","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2025.118601_bib309","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122661","article-title":"An injectable and antifouling hydrogel prevents the development of abdominal adhesions by inhibiting the CCL2\/CCR2 interaction","volume":"311","author":"Wen","year":"2024","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biopha.2025.118601_bib310","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/pharmaceutics14112346","article-title":"Tumor microenvironment-based stimuli-responsive nanoparticles for controlled release of drugs in cancer therapy","volume":"14","author":"Zhou","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib311","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12951-022-01561-z","article-title":"Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment","volume":"20","author":"Gu","year":"2022","journal-title":"J. nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.118601_bib312","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jconrel.2017.03.044","article-title":"CXCR4-targeted combination therapy for the treatment of liver fibrosis","volume":"259","author":"Ullah","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib313","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10856-014-5357-3","article-title":"Enhanced anti-cancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cells","volume":"26","author":"Teong","year":"2015","journal-title":"Journal Materials Science Materials Medicine"},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib314","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/foods11020182","article-title":"Preparation of curcumin hydrogel beads for the development of functional kulfi: a tailoring delivery system","volume":"11","author":"Sharma","year":"2022","journal-title":"Foods"},{"issue":"12","key":"10.1016\/j.biopha.2025.118601_bib315","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/carcin\/bgs312","article-title":"Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and-2","volume":"33","author":"Killian","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib316","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/s41467-019-11869-4","article-title":"CXCR1-or CXCR2-modified CAR t cells co-opt IL-8 for maximal antitumor efficacy in solid tumors","volume":"10","author":"Jin","year":"2019","journal-title":"Nat. Commun."},{"issue":"46","key":"10.1016\/j.biopha.2025.118601_bib317","doi-asserted-by":"crossref","first-page":"1703036","DOI":"10.1002\/adfm.201703036","article-title":"Targeted delivery of CRISPR\/Cas9-mediated cancer gene therapy via liposome-templated hydrogel nanoparticles","volume":"27","author":"Chen","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2025.118601_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119359","article-title":"Cas9-edited immune checkpoint blockade PD-1 DNA polyaptamer hydrogel for cancer immunotherapy","volume":"218","author":"Lee","year":"2019","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib319","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/gels10070440","article-title":"Stimulus-responsive hydrogels for targeted cancer therapy","volume":"10","author":"Solanki","year":"2024","journal-title":"Gels"},{"issue":"7","key":"10.1016\/j.biopha.2025.118601_bib320","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.3390\/ijms24076615","article-title":"Liposomes in cancer therapy: how did we start and where are we now","volume":"24","author":"Fulton","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib321","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.118601_bib322","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251338390","article-title":"Drug delivery system for cancer immunotherapy: potential roles, challenge and recent advances","volume":"24","author":"Lin","year":"2025","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib323","doi-asserted-by":"crossref","first-page":"2400476","DOI":"10.1080\/10717544.2024.2400476","article-title":"Recent advances of injectable in situ-forming hydrogels for preventing postoperative tumor recurrence","volume":"31","author":"Wang","year":"2024","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib324","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12951-025-03613-6","article-title":"Hydrogels as advanced drug delivery platforms for cancer immunotherapy: promising innovations and future outlook","volume":"23","author":"Mohammadzadeh","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.118601_bib325","doi-asserted-by":"crossref","first-page":"1072393","DOI":"10.3389\/fbioe.2022.1072393","article-title":"An engineered hydrogel with low-dose antitumor drugs enhances tumor immunotherapy through tumor interstitial wrap","volume":"10","author":"Li","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"15","key":"10.1016\/j.biopha.2025.118601_bib326","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35524","article-title":"CXCL12-loaded-hydrogel (CLG): a new device for metastatic circulating tumor cells (CTCs) capturing and characterization","volume":"10","author":"Portella","year":"2024","journal-title":"Heliyon"},{"issue":"19","key":"10.1016\/j.biopha.2025.118601_bib327","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1021\/acs.nanolett.4c01267","article-title":"Sustained secretion of CCL21 via an implantable cell reservoir hydrogel enhances the systemic antitumor effect of radiotherapy","volume":"24","author":"Gao","year":"2024","journal-title":"Nano Lett."},{"issue":"8","key":"10.1016\/j.biopha.2025.118601_bib328","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/biomedicines13081899","article-title":"Research strategies and methods of hydrogels for antitumor drug delivery","volume":"13","author":"Zeng","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118601_bib329","author":"Sen","year":"2025","journal-title":"Evol. Transp. Prop. Dyn. hydrogels enable selfTuning Short. Long. Term. Cargo Deliv. arXiv Prepr."},{"key":"10.1016\/j.biopha.2025.118601_bib330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.106758","article-title":"Smart hydrogels and the promise of multi-responsive in-situ systems","author":"Jahanbekam","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118601_bib331","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118601_bib332","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40425-017-0300-z","article-title":"Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the society for immunotherapy of cancer (SITC) toxicity management working group","volume":"5","author":"Puzanov","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2025.118601_bib333","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:46:05Z","timestamp":1775781965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":333,"alternative-id":["S0753332225007954"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118601","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fighting cancer smarter: Using hydrogel delivery systems to target chemokines","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118601"}}